Global Reporting Initiative (GRI) G3.1 Allergan Index

More documents

Recommendations

Info

3.3 Reporting Cycle Annual Report Allergan reports on a calendar yearannual cycleSustainability Performance Report Allergan reportssustainability performance on an annual cycle3.4 Contact for Questions Regarding the Report Allergan Contact InformationMichael Whaley – Sr. Director, EHS at 714-246-5492 orWhaley_Michael@Allergan.com3.5 Process for Defining Report Content Responsibility - EHSGlobal Reporting Initiative3.6 Limits of the Reporting Procedure Annual ReportResponsibility - EHSSustainability Performance Report3.7 Limitations of the Scope of the Report Annual ReportResponsibility - EHSSustainability Performance Report3.8 Joint Ventures, Subsidiaries, Outsourcing Research and Development PipelineResearch and Development Collaborations3.9 Data Capture Annual ReportResponsibility - EHSSustainability Performance Report3.10 Changes in the Presentation of InformationCompared to Earlier Reports3.11 Changes in the Scope and Limitations of the Reportor in the Measurement Methods AppliedAnnual ReportResponsibility - EHSSustainability Performance ReportAnnual ReportResponsibility - EHSSustainability Performance Report3.12 Index According GRI with Links This document represents Allergan’s in accordancestatement with the GRI Index G33.13 Verification: External Verification of theStatementsAnnual ReportResponsibility - EHSSustainability Performance Report4. Management Obligations and Commitment Corporate GovernanceResearch and Development4.1 Governance Structure Corporate GovernanceCorporate GuidelinesAllergan BylawsLeadershipAllergan Corporate CharterAllergan Code of Conduct4.2 Independence of Supervisory Board Chairman Corporate GovernanceCorporate Guidelines
4.3 Governance Body and/or Independent Members ofManagement4.4 Mechanisms for Stockholders and Employees toProvide Recommendations to the Board of Managementor the Supervisory Board4.5 Linkage Between Board Management Compensationand Company Performance4.6 Mechanism in Place for the Governance Bodies toEnsure Avoidance of Conflicts of Interest4.7 Expertise of the Governance Bodies in SustainableIssues4.8 Mission Statements, Company Values and Codes ofConduct4.9 Procedures of the Board of Management orSupervisory Board for Overseeing SustainabilityPerformance4.10 Processes for Evaluating the Performance of theBoard of ManagementLeadershipCorporate GuidelinesAllergan BylawsAllergan Code of ConductCorporate GuidelinesAllergan BylawsAllergan Code of ConductCorporate GovernanceSustainability Performance ReportCorporate GuidelinesAllergan BylawsAllergan Code of ConductResearch and DevelopmentAllergan FoundationPatient ResourcesPhysician ResourcesProfessional AffiliationsEducational GrantsComplianceResponsibility - EHSSustainability Performance ReportAnnual ReportShareholder InformationSustainability Performance ReportAnnual ReportShareholder InformationCorporate GuidelinesAllergan BylawsAllergan Code of Conduct4.11 Implementation of the Precautionary Principle Sustainability Performance ReportAnnual ReportShareholder Information4.12 Support of External Initiatives Research and DevelopmentAllergan FoundationPatient ResourcesPhysician ResourcesProfessional AffiliationsEducational GrantsComplianceResponsibility - EHSSustainability Performance ReportAnnual ReportShareholder Information4.13 Principal Memberships in Industry and BusinessAssociationsResearch and DevelopmentAllergan FoundationPatient Resources
Page 1: Global Reporting Initiative (GRI) G
Page 5 and 6: 5. Performance IndicatorsEconomicsM
Page 7 and 8: EN15. Number of ICUN Red List speci
Page 9 and 10: management-employee health and safe
Page 11 and 12: esolved through formal grievance me
Page 13: PR7. Total number of incidents of n

Global Reporting Initiative (GRI) G3.1 Allergan Index

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?